AZIYO BIOLOGICS INC-CLASS A (AZYO) Stock Analyst Earnings Estimates
NASDAQ:AZYO - Nasdaq - US05479K1060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 42.68M -0.51% | 47.39M 11.04% | 49.187M 3.79% | 43.554M -11.45% | 52.326M 20.14% | |
| EBITDA YoY % growth | -9.74M -114.07% | -19.302M -98.17% | -22.807M -18.16% | -23.971M -5.10% | -18.954M 20.93% | |
| EBIT YoY % growth | -13.6M -61.71% | -23.032M -69.35% | -26.54M -15.23% | -14.688M 44.66% | -17.748M -20.83% | |
| Operating Margin | -31.87% | -48.60% | -53.96% | -33.72% | -33.92% | |
| EPS YoY % growth | N/A | -2.71 55.29% | -2.40 11.44% | -2.17 9.47% | -1.46 32.86% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.57 21.75% | -0.45 -18.11% | -0.43 11.32% | -0.49 24.36% | -0.47 17.32% | -0.48 -7.27% |
| Revenue Q2Q % growth | 9.69M -21.79% | 10.098M -20.27% | 13.626M 4.41% | 16.787M 63.04% | 17.073M 76.19% | 18.568M 83.88% |
| EBITDA Q2Q % growth | -6.185M -75.57% | -6.167M -239.21% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.65M -21.06% | -6.63M -19.44% | -6.609M -46.63% | -7.806M 0.10% | -7.46M 2.48% | -7.706M -16.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.65 5.80% | -0.30 | -0.35 | -119.74% |
| Q1 2023 Q2Q % growth | -0.49 18.33% | -0.55 | 0.06 | 11.04% |
| Q4 2022 Q2Q % growth | -0.38 53.66% | -0.70 | 0.32 | 46.01% |
| Q3 2022 Q2Q % growth | -0.73 9.88% | -0.68 | -0.05 | -7.70% |
| Q2 2022 Q2Q % growth | -0.69 -18.97% | -0.57 | -0.12 | -21.34% |
| Q1 2022 Q2Q % growth | -0.60 -20.00% | -0.64 | 0.04 | 5.63% |
| Q4 2021 Q2Q % growth | -0.82 -43.86% | -0.70 | -0.12 | -17.79% |
| Q3 2021 Q2Q % growth | -0.81 92.20% | -0.63 | -0.18 | -27.57% |
| Q2 2021 Q2Q % growth | -0.58 | -0.54 | -0.04 | -6.78% |
| Q1 2021 Q2Q % growth | -0.50 | -0.58 | 0.08 | 13.50% |
| Q4 2020 Q2Q % growth | -0.57 | -0.51 | -0.06 | -11.49% |
| Q3 2020 Q2Q % growth | -10.38 | -4.46 | -5.92 | -132.87% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 10.296M -18.53% | 12.75M | -2.454M | -19.25% |
| Q1 2023 Q2Q % growth | 13.05M 13.53% | 13.974M | -924K | -6.61% |
| Q4 2022 Q2Q % growth | 12.665M 16.61% | 12.801M | -136K | -1.06% |
| Q3 2022 Q2Q % growth | 12.389M 7.87% | 12.623M | -234K | -1.85% |
| Q2 2022 Q2Q % growth | 12.638M 3.93% | 11.812M | 826K | 6.99% |
| Q1 2022 Q2Q % growth | 11.495M -10.75% | 10.991M | 504K | 4.59% |
| Q4 2021 Q2Q % growth | 10.861M -12.90% | 11.279M | -418K | -3.71% |
| Q3 2021 Q2Q % growth | 11.485M -2.42% | 11.709M | -224K | -1.91% |
| Q2 2021 Q2Q % growth | 12.16M 41.72% | 12.281M | -121K | -0.99% |
| Q1 2021 Q2Q % growth | 12.88M 30.63% | 11.406M | 1.474M | 12.92% |
| Q4 2020 Q2Q % growth | 12.47M 3.49% | 11.878M | 592K | 4.98% |
| Q3 2020 Q2Q % growth | 11.77M 5.66% | 11.437M | 333K | 2.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -133.33% | -55.56% | -76.03% | -33.12% |
| Revenue | 48.44% | -36.24% | 12.37% | -27.38% |